/Investor DB

Intuitive Ventures

Corporate VCventure arm of Intuitive

Sunnyvale · Seed–Series A · 16 people tracked

Find your way into Intuitive Ventures

Sign up to see every warm intro you have to Intuitive Ventures

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Intuitive Ventures team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Intuitive Ventures backs teams working on next-horizon healthcare challenges, aiming to improve care in measurable ways while generating meaningful returns. Rooted in Intuitive's founding principles but with a wide-angle view, the firm invests across diverse healthcare needs and pursues innovations that transcend conventional thinking. It draws on decades of technical, clinical, regulatory, and commercial experience to guide teams from early-stage development through global expansion, offering practical support and network access beyond capital. The firm prioritizes coachable teams with intellect, integrity, and resilience, applying a rigorous, data-grounded process to help founders move faster with fewer missteps.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Series A
HQ
Sunnyvale, California, US
Leads rounds
Follows
Instruments
Equity
Founded
2020
Last 12 months
1 investment
AUM
$250M
Tracked investments
20

Team · 16 people

from the firm's website & public directories
Bob DeSantis· Venture Advisor
Vijay Rajasekhar· Associate, MD, MBA
Vijayalakshmi (Viji) Thyagarajan· Executive Assistant
Vivian Golfin (De Ruijter)· Senior Associate, MD

Founder mafia

4 people who came through Intuitive Ventures went on to found or lead other companies.

What they invest in

from 15 of 20 portfolio companies

Medical Devices ×14Healthtech ×12AI & Machine Learning ×4Biotech ×4Digital Health ×3Data & Infrastructure ×2Robotics ×2Advanced Manufacturing ×1

HQs:United States×13United Kingdom×2

Who they back

founder profiles across 8 portfolio companies
38%
solo founders
3 of 8 mapped founding teams

Founding team size:solo founder×32 founders×23 founders×24+ founders×1

Investments · 20 tracked

founders shown can be your intro path

By year:2025 · 22024 · 12022 · 42021 · 52020 · 315 dated

MedCryptmedcrypt.comin𝕏Series B · Nov 2022 · $25M✓ verified

Medcrypt provides cybersecurity products and strategic consulting to medical device manufacturers to ensure their devices are secure by design and meet FDA regulatory requirements.

CybersecurityHealthtechMedical DevicesSaaSSan Diego, US

Eric Pancoast(CTO)inMike Kijewski(CEO)inVidya Murthy(VP of Operations)inWilliam Fenstermaker(Founder)Om Mahida(Engineer)Erin Murphree(talent acquisition)

Co-investorsEniac VenturesY CombinatorSection 32Alumni VenturesAnzu PartnersDolby Family Ventures+10 more

Neocisneocis.comin𝕏Oct 2022 · $40M✓ verified

Neocis develops Yomi, a robotic surgical platform that assists clinicians during dental implant surgery with planning, surgical, and restorative software features.

HealthtechMedical DevicesRoboticsMiami, US

Alon Mozes(Founder)inJuan Salcedo(Founder)inDennis Moses(Chief Technical Officer)inAndres Carrillo(VP of Product)inJorge Fernandes(VP of Quality & Regulatory)inGabe Goldberg(VP of Marketing)in

Co-investorsNorwest Venture PartnersVivo CapitalCLI VenturesFlorida Opportunity FundMithril Capital ManagementB Capital Group+4 more

Vahaticorvahaticor.cominNov 2025✓ verified

VahatiCor is developing the A-FLUX Reducer System, an interventional device to treat coronary microvascular dysfunction, a condition affecting millions of patients—particularly women—who experience chest pain and cardiac symptoms despite normal standard angiography results.

HardwareHealthtechMedical DevicesSanta Clara, US

Marwan Berrada(Founder and Chairman)inHarry Rowland(CEO)inKevin Van Bladel(Chief Technology Officer)inMark Niggli(Chief Commercial Officer)inMarwan Berrada-Sounni(Executive Officer, Director)in

BoardBrian R. Smith(Director)in

Co-investorsS3 Ventures

Amber Therapeuticsamber-tx.comin

Amber Therapeutics develops medical technology focused on treating mixed urinary incontinence, advancing toward pivotal clinical trials in the US with expanded feasibility studies in Europe.

Medical Devices

Co-investorsF-Prime CapitalLightstone VenturesNew Enterprise Associates (NEA)Oxford Science Enterprises

Apreo Healthapreohealth.cominAug 2025

Apreo Health develops a bronchoscopic treatment for severe emphysema using a self-expanding airway scaffold designed to reduce trapped air and improve lung function.

BiotechHealthtechMedical DevicesMenlo Park, US

Karun Durgam Naga(Executive Officer, Director)

BoardHanson S. Gifford III(Director)Zack Scott(Director)inMichael A. Carusi(Director)Drew Field(Director)inDennis McWilliams(Director)in

Co-investorsF-Prime CapitalLightstone VenturesNorwest Venture PartnersStar51 Capital

Capstancapstanmedical.cominDec 2024 · $110M

Capstan Medical develops surgical robotics combined with catheter-based technology and next-generation implants to repair and replace heart valves.

HealthtechMedical DevicesRobotics

Dan Wallace(Founder)inMaggie Nixon(Founder)

Co-investorsEclipse VenturesStar51 CapitalEclipseYu Galaxy

Cellarescellares.cominApr 2021 · $257M

Cellares develops automated manufacturing systems and technology platforms to accelerate the production and commercialization of cell therapies.

Advanced ManufacturingBiotechMedical DevicesSouth San Francisco, US

Fabian Gerlinghaus(Founder)inOmar Kurdi(Founder)inAlex Pesch(Founder)Fabian Gerlinghaus Omar Kurdi(Founder)

BoardJustin Butler(Director)inVictor Tong(Director)in

Co-investorsDecheng Capital8VCEcoR1 CapitalKoch Disruptive TechnologiesBaillie GiffordBlackRock+4 more

Endogenexendogenex.comin𝕏Apr 2021 · $12M

Endogenex is a clinical-stage medical device company developing the pulsENDO system, which applies non-thermal pulsed electric field to reset the body's metabolic signaling and improve function in people with type 2 diabetes.

Digital HealthHealthtechMedical DevicesMinneapolis, US

Stacey Pugh(Leadership (CEO))inChris Sorli, MD, PhD(Chief Medical Officer)inKrissy Wright(Chief Financial Officer)inLian Cunningham, MD, PhD(VP Clinical Affairs)inMelanie Hess(Regulatory Affairs Leadership)inMatt Cambronne(Technical/Engineering Leadership)in

Co-investorsArboretum VenturesHatteras Venture PartnersLongitude CapitalLumira VenturesSoutheast Minnesota Capital Fund

Flywheelflywheel.ioin𝕏Series C · Sep 2021 · $27M

Flywheel provides a platform for organizing, managing, and sharing medical imaging data.

AI & Machine LearningData & InfrastructureHealthtechMedical DevicesMinneapolis, US

Brian Wandell(Co-founder)Gunnar Schaefer(Co-founder)inColby Moosman(Executive Officer)inMatthew D. Michela(Executive Officer, Director)inSarah Fazio(Executive Officer)Jim Olson(Executive Officer)in

Co-investors8VCAlumni VenturesBeringeaGreat North VenturesiSelect FundLightbank+4 more

Kela Healthkelahealth.comin𝕏Oct 2020

KelaHealth develops data-driven solutions that apply insights from millions of patient records to personalize and improve medical decision-making.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechMedical DevicesSan Francisco, US

Bora Chang(Executive Officer, Director)

BoardDennis McWilliams(Director)

Co-investorsBlue Hour VenturesNC IDEANueterra CapitalTechstarsSante Ventures

Optellumoptellum.comSeries A · Sep 2022 · $14M

Optellum builds an AI-powered platform for early lung cancer diagnosis, helping thoracic care teams and health systems discover, track, and assess the malignancy risk of lung nodule patients.

AI & Machine LearningHealthtechMedical Devices

Co-investorsBlack Opal VenturesIQ CapitalMercia VenturesOutsized Ventures

OrganOxorganox.comin

OrganOx develops the metra platform, a device that extends organ preservation time for liver transplants by maintaining continuous perfusion with oxygenated blood-based solutions, enabling surgeons to better assess organ viability and make more informed transplant decisions.

BiotechHealthtechMedical DevicesOxford, GB

Prof. Peter Friend(Co-Founder)

Co-investorsAmadeus Capital PartnersAnjostBusiness Growth FundHealthQuest CapitalLauxera Capital PartnersLongwall Venture Partners LLP+2 more

Roambeeroambee.comin𝕏Jan 2020 · $15.2M

Roambee (Decklar) offers a real-time decision AI platform for supply chains, providing shipment and asset visibility across ocean, air, road, and rail, along with automation and planning tools.

AI & Machine LearningIoTLogistics & Supply ChainSanta Clara, US

Sanjay Sharma(Chairman & Chief Executive Officer)inVidya Subramanian(Executive Officer, Director)inMeenakshi Singh(Executive Officer)

Co-investorsReefknot InvestmentsTemasek

SURGEsurgetx.com𝕏

SURGE develops clinical approaches for cancer immunotherapy and post-surgical cancer recurrence prevention.

BiotechHealthtechMedical Devices

Michael Goldberg(CEO)in

Co-investorsAlumni Ventures

XII Medicalxiimedical.comin

XII Medical develops neuromodulation therapies for treating obstructive sleep apnea, focusing on simplifying treatment options and improving patient outcomes.

Deep TechDigital HealthHealthtechMedical DevicesUnion City, US

Garrett Schwab(Chief Executive Officer)inShane Kreidel(Secretary and Chief Financial Officer)inZachary Eisen(Director)

BoardDuke Rohlen(Director)inJD Friedland(Director)Saoussen Ben Halima(Director)

Co-investorsAPERTURE Venture PartnersBroadview VenturesCincyTechJobsOhio VenturesAjax HealthOmega Funds

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Dragon VascularInvenshureKelaHealthSURGE Therapeutics

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Intuitive Ventures made?
Intuitive Ventures has 20 tracked investments, including 3 dated in the last 24 months.
What stage does Intuitive Ventures invest at?
Intuitive Ventures invests at the Seed, Series A stages.
What sectors does Intuitive Ventures focus on?
Intuitive Ventures focuses on Biotech, Digital Health, Enterprise Software, Healthtech, Medical Devices.
Where is Intuitive Ventures located?
Intuitive Ventures is headquartered in Sunnyvale, US.
Does Intuitive Ventures lead rounds?
Intuitive Ventures typically participates in rounds rather than leading them.
Who does Intuitive Ventures co-invest with?
Intuitive Ventures most often shares deals with Alumni Ventures, 8VC, F-Prime Capital, among 51 tracked co-investors.
What size deals does Intuitive Ventures back?
Across 7 deals with disclosed amounts, Intuitive Ventures has joined rounds of $12M – $257M (median $27M).

Media · Podcasts & interviews

featuring the team

Murielle Thinard McLane, Intuitive Ventures | Interview at LSI Europe ‘23

LSI - Life Science Intelligence™ · Murielle Thinard McLane

He left Wall Street to become a surgeon | Intuitive Presents Portraits of Care

Intuitive

Da Vinci Weight Loss Surgery: Sarah’s journey of success, after GLP1s

Intuitive

The first question most patients ask is ‘when can I go home?’ | After Hours episode 3

Intuitive

Images

Intuitive Ventures photoIntuitive Ventures photoIntuitive Ventures photo

Co-investors · 5

8VC

8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.

$500K – $50M
S32

S32 is a venture capital firm investing at the frontiers of technology, backing exceptional founders with conviction-based investing led by experienced partners.

Both backed · 1
Mithril Capital Management

Mithril Capital Management is a multi-billion-dollar investment firm launched in 2012 with a 'Building to Last' mission, backing technology teams building durable businesses in industries overdue for change. Its committed funds are anchored by investor Peter Thiel.

Both backed · 1
M12 (Microsoft's Venture Fund)

M12 is Microsoft's corporate venture capital fund, investing in innovative startups and leveraging Microsoft's resources, connections, and customers to help portfolio companies scale.

$100K – $10M
Sonder Capital

Sonder Capital is a venture firm that invests in teams and technologies aiming to transform healthcare across the medical device, diagnostic, and healthtech sectors. It positions itself as a hands-on, foundational early-stage investor that supports companies from inception through acquisition or IPO.

Firms observed investing alongside Intuitive Ventures, from public investor directories. Shared companies are the overlap with Intuitive Ventures's recorded portfolio.

Similar investors

Featured in lists